Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Hypospadiac rats showed abnormal genital development, useful for studying human hypospadias.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

A young man had a rare case of hair cysts on his elbows, which was hard to diagnose and treat.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

A man had two rare autoimmune diseases that might be connected.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Sleeping on a waterbed caused a skin infection, which cleared up with clindamycin gel.

SHH protein helps nerve regeneration in hypertensive rats.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Flutamide-induced hypospadias in rats slows down early wound healing.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Man experienced lasting sexual dysfunction from finasteride, but malpractice claim was rejected.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Dutasteride for hair loss might increase the risk of a rare stroke type.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Vogt–Koyanagi–Harada disease can cause rare hair growth on normally hairless thumb skin.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Treatment improved some symptoms but not all.